Detalles de la búsqueda
1.
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(9)2021 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33922388
2.
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
BMC Cancer
; 17(1): 502, 2017 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28747156
3.
INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung Cancer.
J Cancer
; 12(13): 3781-3795, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34093787
4.
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy.
Genes (Basel)
; 12(7)2021 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34209514
5.
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
Genes (Basel)
; 12(2)2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33671892
6.
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations.
Genes (Basel)
; 12(5)2021 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33946594
7.
Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.
Genes (Basel)
; 11(8)2020 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32806537
8.
Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR.
Diagnostics (Basel)
; 10(12)2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33297595
9.
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
Tumori
; 94(3): 398-405, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18705409
10.
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer.
Eur J Cardiothorac Surg
; 52(6): 1077-1082, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28977471
11.
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study.
Oncotarget
; 8(47): 83343-83353, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137348
12.
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer.
Clin Cancer Res
; 10(18 Pt 1): 6006-12, 2004 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15447984
13.
Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Lung Cancer
; 46(1): 77-85, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15364135
14.
Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients.
J Thorac Oncol
; 6(12): 2018-26, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22052224
15.
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 6(4): 707-15, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21258250
16.
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
J Thorac Oncol
; 3(4): 365-73, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18379354
Resultados
1 -
16
de 16
1
Próxima >
>>